News
For patients with active nonsegmental vitiligo, treatment often requires a multifaceted approach to achieve meaningful repigmentation. In a recently published phase 2b extension study, adding ...
With some big changes to the core experience and multiple progression alterations to help players get reacquainted with the game, this could be Lost Ark's moment. Earlier this month, Smilegate ...
Ivonescimab combined with chemotherapy showed significant progression-free survival benefits in advanced squamous NSCLC patients, including both PD-L1-positive and PD-L1-negative populations. The ...
The combination of Gilead’s anti-TROP2 antibody-drug conjugate Trodelvy and Merck’s PD-1 blocker Keytruda boosted progression-free survival as a frontline regimen in patients with a highly aggressive ...
Twenty-four-week results showed Tremfya reduced signs, symptoms and structural progression of the disease. Perspective from Anthony P. Fernandez, MD, PhD Tremfya reduced signs and symptoms of ...
And new research suggests senolytics may potentially help slow the progression of Alzheimer’s disease, which is raising a bunch of questions in the scientific community about how effective they ...
BRIDGEWATER, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results